Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | IDXX | Common Stock | Options Exercise | $17.7K | +276 | +9.6% | $64.24* | 3.15K | Aug 27, 2021 | Direct | F1 |
transaction | IDXX | Common Stock | Sale | -$187K | -276 | -8.76% | $678.00 | 2.88K | Aug 27, 2021 | Direct | |
transaction | IDXX | Common Stock | Options Exercise | $179K | +2.25K | +78.25% | $79.54* | 5.13K | Aug 30, 2021 | Direct | |
transaction | IDXX | Common Stock | Sale | -$685K | -1K | -19.51% | $685.00 | 4.13K | Aug 30, 2021 | Direct | |
transaction | IDXX | Common Stock | Sale | -$861K | -1.25K | -30.3% | $689.00 | 2.88K | Aug 30, 2021 | Direct | |
holding | IDXX | Common Stock | 100 | Aug 27, 2021 | by spouse | F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | IDXX | Non-Qualified Stock Option (right-to-buy) | Options Exercise | -276 | -100% | 0 | Aug 27, 2021 | Common Stock | 276 | $64.24 | Direct | F3, F5 | ||
transaction | IDXX | Non-Qualified Stock Option (right-to-buy) | Options Exercise | -2.25K | -22.53% | 7.74K | Aug 30, 2021 | Common Stock | 2.25K | $79.54 | Direct | F4, F5 |
Id | Content |
---|---|
F1 | Includes a total of 9.3869 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on June 30, 2021. |
F2 | The reporting person disclaims beneficial interest of the shares of common stock held by her spouse except to the extent of her pecuniary interest therein. |
F3 | Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable as to 138 shares in five annual installments beginning June 1, 2015, without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split. |
F4 | Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable as to 4,993 shares in five annual installments beginning February 15, 2016, without giving effect to the Stock Split. The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split. |
F5 | Not applicable. |